Unilateral nephrectomy causes an abrupt increase in inflammatory mediators and a simultaneous decrease in plasma ADMA: A study in living kidney donors

American Journal of Physiology - Renal Physiology

Volumn 301, Issue 5, 2011, Pages

  Kielstein, Jan T ^a   Veldink, Hendrik ^a   Martens Lobenhoffer, Jens ^b   Haller, Hermann ^a   Perthel, Ronny ^a   Lovric, Svjetlana ^a   Lichtinghagen, Ralf ^d   Kliem, Volker ^c   Bode Böger, Stefanie M ^b  

^a Clinic of Nephrology and Hypertension   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c Nephrological Centre Lower Saxony   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

L arginine; Sepsis; Transplantation

Indexed keywords

ARGININE; C REACTIVE PROTEIN; INTERLEUKIN 6; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KIDNEY DONOR; LIVING DONOR; MALE; MEDIATOR; NORMAL HUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; UNINEPHRECTOMY;

EID: 80055066598     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00640.2010     Document Type: Article

References (35)

1. Billecke SS, D'Alecy LG, Platel R, Whitesall SE, Jamerson KA, Perlman RL, Gadegbeku CA. Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease. Nephrol Dial Transplant 24: 489-496, 2009.
2. Billecke SS, Kitzmiller LA, Northrup JJ, Whitesall SE, Kimoto M, Hinz AV, D'Alecy LG. Contribution of whole blood to the control of plasma asymmetrical dimethylarginine. Am J Physiol Heart Circ Physiol 291: H1788-H1796, 2006.
3. Blackwell S, O'Reilly DS, Reid D, Talwar D. Plasma dimethylarginines during the acute inflammatory response. Eur J Clin Invest 41: 635-641, 2011.
4. Blackwell S, O'Reilly DS, Talwar D. Biological variation of asymmetric dimethylarginine and related arginine metabolites and analytical performance goals for their measurement in human plasma. Eur J Clin Invest 37: 364-371, 2007.
5. Boger RH, Sullivan LM, Schwedhelm E, Wang TJ, Maas R, Benjamin EJ, Schulze F, Xanthakis V, Benndorf RA, Vasan RS. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation 119: 1592-1600, 2009.
6. Brosnan ME, Brosnan JT. Renal arginine metabolism. J Nutr 134: 2791S-2795S, 2004.
7. Carello KA, Whitesall SE, Lloyd MC, Billecke SS, D'Alecy LG. Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats. Am J Physiol Heart Circ Physiol 290: H209-H216, 2006.
8. Closs EI, Basha FZ, Habermeier A, Forstermann U. Interference of L-arginine analogues with L-arginine transport mediated by the y carrier hCAT-2B. Nitric Oxide 1: 65-73, 1997.
9. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 20: 2032-2037, 2000.
10. Eid HM, Lyberg T, Arnesen H, Seljeflot I. Insulin and adiponectin inhibit the TNFalpha-induced ADMA accumulation in human endothelial cells: the role of DDAH. Atherosclerosis 194: e1-e8, 2007.
11. Fliser D, Kronenberg F, Kielstein JT, Morath C, Bode-Boger SM, Haller H, Ritz E. Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study. J Am Soc Nephrol 16: 2456-2461, 2005.
12. Hattori Y, Kasai K, Gross SS. Cationic amino acid transporter gene expression in cultured vascular smooth muscle cells and in rats. Am J Physiol Heart Circ Physiol 276: H2020-H2028, 1999.
13. Iapichino G, Umbrello M, Albicini M, Spanu P, Bellani G, Polli F, Pavlovic R, Cugno M, Fermo I, Paroni R. Time course of endogenous nitric oxide inhibitors in severe sepsis in humans. Minerva Anestesiol 76: 325-333, 2010.
14. Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99: 3092-3095, 1999.
15. Kielstein JT, Bode-Boger SM, Hesse G, Martens-Lobenhoffer J, Takacs A, Fliser D, Hoeper MM. Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol 25: 1414-1418, 2005.
16. Kielstein JT, Boger RH, Bode-Boger SM, Schaffer J, Barbey M, Koch KM, Frolich JC. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10: 594-600, 1999.
17. Kielstein JT, Hesse G, Bahr MJ, Tsikas D, Terkamp C, Martens- Lobenhoffer J, Manns MP, Haller H, Panning B, Bode-Boger SM, Gebel M. Procedure-related pulmonary hypertension in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection-role of ethanol, hemolysis, asymmetric dimethylarginine, and the nitric oxide system. Crit Care Med 37: 1483-1485, 2009.
18. Kielstein JT, Veldink H, Martens-Lobenhoffer J, Haller H, Burg M, Lorenzen JM, Lichtinghagen R, Bode-Boger SM, Kliem V. SDMA is an early marker of change in GFR after living-related kidney donation. Nephrol Dial Transplant 26: 324-328, 2011.
19. Martens-Lobenhoffer J, Bode-Boger SM. Fast and efficient determination of arginine, symmetric dimethylarginine, and asymmetric dimethylarginine in biological fluids by hydrophilic-interaction liquid chromatography- electrospray tandem mass spectrometry. Clin Chem 52: 488-493, 2006.
20. Mittermayer F, Namiranian K, Pleiner J, Schaller G, Wolzt M. Acute Escherichia coli endotoxaemia decreases the plasma L-arginine/asymmetrical dimethylarginine ratio in humans. Clin Sci (Lond) 106: 577-581, 2004.
21. Najarian JS, Chavers BM, McHugh LE, Matas AJ. 20 years or more of follow-up of living kidney donors. Lancet 340: 807-810, 1992.
22. Nijveldt RJ, Siroen MP, Teerlink T, van Lambalgen AA, Rauwerda JA, Van Leeuwen PA. Gut and liver handling of asymmetric and symmetric dimethylarginine in the rat under basal conditions and during endotoxemia. Liver Int 24: 510-518, 2004.
23. Nijveldt RJ, Teerlink T, van GC, Prins HA, van Lambalgen AA, Stehouwer CD, Rauwerda JA, Van Leeuwen PA. Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia. Nephrol Dial Transplant 18: 2542-2550, 2003.
24. O'Dwyer MJ, Dempsey F, Crowley V, Kelleher DP, McManus R, Ryan T. Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study. Crit Care 10: R139, 2006.
25. Ravani P, Tripepi G, Malberti F, Testa S, Mallamaci F, Zoccali C. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach. J Am Soc Nephrol 16: 2449-2455, 2005.
26. Richir MC, van Lambalgen AA, Teerlink T, Wisselink W, Bloemena E, Prins HA, de Vries TP, Van Leeuwen PA. Low arginine/asymmetric dimethylarginine ratio deteriorates systemic hemodynamics and organ blood flow in a rat model. Crit Care Med 37: 2010-2017, 2009.
27. Schmidt RJ, Baylis C. Total nitric oxide production is low in patients with chronic renal disease. Kidney Int 58: 1261-1266, 2000.
28. Teerlink T, Luo Z, Palm F, Wilcox CS. Cellular ADMA: regulation and action. Pharmacol Res 60: 448-460, 2009.
29. Ueda S, Kato S, Matsuoka H, Kimoto M, Okuda S, Morimatsu M, Imaizumi T. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase. Circ Res 92: 226-233, 2003.
30. Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Le Gall JR. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no 144-002). Crit Care Med 32: 13-20, 2004.
31. Xin HY, Jiang DJ, Jia SJ, Song K, Wang GP, Li YJ, Chen FP. Regulation by DDAH/ADMA pathway of lipopolysaccharide-induced tissue factor expression in endothelial cells. Thromb Haemost 97: 830-838, 2007.
32. Zoccali C, Benedetto FA, Maas R, Mallamaci F, Tripepi G, Malatino LS, Boger R. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol 13: 490-496, 2002.
33. Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frolich J, Boger R. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358: 2113-2117, 2001.
34. Zoccali C, Kielstein JT. Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease? Curr Opin Nephrol Hypertens 15: 314-320, 2006.
35. Zoccali C, Maas R, Cutrupi S, Pizzini P, Finocchiaro P, Cambareri F, Panuccio V, Martorano C, Schulze F, Enia G, Tripepi G, Boger R. Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections. Nephrol Dial Transplant 22: 801-806, 2007.